T.
ROWE
PRICE
Blue
Chip
Growth
Fund
September
30,
2023
(Unaudited)
1
Portfolio
of
Investments
‡
Shares/Par
$
Value
(Cost
and
value
in
$000s)
‡
COMMON
STOCKS
98.9%
COMMUNICATION
SERVICES
15.9%
Entertainment
1.5%
Netflix (1)
1,756,402
663,217
Sea,
ADR (1)(2)
2,594,629
114,034
777,251
Interactive
Media
&
Services
13.4%
Alphabet,
Class
A (1)
6,040,209
790,422
Alphabet,
Class
C (1)
26,820,668
3,536,305
Meta
Platforms,
Class
A (1)
8,378,817
2,515,404
6,842,131
Wireless
Telecommunication
Services
1.0%
T-Mobile
U.S. (1)
3,634,583
509,023
509,023
Total
Communication
Services
8,128,405
CONSUMER
DISCRETIONARY
14.7%
Automobiles
2.9%
Tesla (1)(2)
5,865,816
1,467,744
1,467,744
Broadline
Retail
7.7%
Amazon.com (1)
30,928,287
3,931,604
3,931,604
Hotels,
Restaurants
&
Leisure
2.0%
Booking
Holdings (1)
153,026
471,925
Chipotle
Mexican
Grill (1)
247,355
453,112
DoorDash,
Class
A (1)(2)
1,532,503
121,788
1,046,825
Specialty
Retail
1.3%
Carvana (1)(2)
2,619,236
109,956
Ross
Stores
2,671,759
301,775
TJX
2,786,457
247,660
659,391
Textiles,
Apparel
&
Luxury
Goods
0.8%
Lululemon
Athletica (1)
645,744
249,005
NIKE,
Class
B
1,532,951
146,581
395,586
Total
Consumer
Discretionary
7,501,150
T.
ROWE
PRICE
Blue
Chip
Growth
Fund
2
Shares/Par
$
Value
(Cost
and
value
in
$000s)
‡
CONSUMER
STAPLES
0.7%
Consumer
Staples
Distribution
&
Retail
0.4%
Dollar
General (2)
1,790,425
189,427
189,427
Food
Products
0.3%
Mondelez
International,
Class
A (2)
2,198,400
152,569
152,569
Total
Consumer
Staples
341,996
ENERGY
0.4%
Energy
Equipment
&
Services
0.4%
Schlumberger
3,233,099
188,490
Total
Energy
188,490
FINANCIALS
10.0%
Capital
Markets
1.7%
Charles
Schwab
3,102,703
170,338
Goldman
Sachs
Group
406,393
131,497
Morgan
Stanley
2,932,603
239,506
MSCI (2)
124,614
63,937
S&P
Global
714,797
261,194
866,472
Financial
Services
6.5%
Adyen
(EUR) (1)
103,052
76,406
Affirm
Holdings (1)(2)
1,832,977
38,987
ANT
Group,
Acquisition
Date:
8/14/23,
Cost $37,936 (1)(3)(4)
37,935,948
37,147
Fiserv (1)
945,989
106,859
Mastercard,
Class
A
3,531,011
1,397,963
Visa,
Class
A (2)
7,182,162
1,651,969
3,309,331
Insurance
1.8%
Chubb (2)
2,603,624
542,022
Marsh
&
McLennan
1,873,064
356,444
898,466
Total
Financials
5,074,269
HEALTH
CARE
13.1%
Health
Care
Equipment
&
Supplies
2.3%
Align
Technology (1)
173,787
53,061
Intuitive
Surgical (1)
2,607,070
762,021
Stryker
1,093,615
298,852
Teleflex (2)
309,461
60,781
1,174,715
T.
ROWE
PRICE
Blue
Chip
Growth
Fund
3
Shares/Par
$
Value
(Cost
and
value
in
$000s)
‡
Health
Care
Providers
&
Services
4.6%
Elevance
Health
459,518
200,083
Humana
752,585
366,148
UnitedHealth
Group
3,544,058
1,786,879
2,353,110
Health
Care
Technology
0.3%
Veeva
Systems,
Class
A (1)(2)
646,229
131,475
131,475
Life
Sciences
Tools
&
Services
2.0%
Danaher (2)
1,548,792
384,255
Thermo
Fisher
Scientific
1,282,334
649,079
1,033,334
Pharmaceuticals
3.9%
AstraZeneca,
ADR (2)
1,997,518
135,272
Eli
Lilly
2,939,295
1,578,784
Zoetis
1,704,226
296,501
2,010,557
Total
Health
Care
6,703,191
INDUSTRIALS
&
BUSINESS
SERVICES
2.1%
Aerospace
&
Defense
0.2%
TransDigm
Group (1)(2)
147,910
124,707
124,707
Commercial
Services
&
Supplies
0.2%
Cintas (2)
190,723
91,740
91,740
Ground
Transportation
0.4%
Old
Dominion
Freight
Line (2)
544,815
222,906
222,906
Industrial
Conglomerates
1.3%
General
Electric
2,377,069
262,785
Roper
Technologies
791,300
383,211
645,996
Total
Industrials
&
Business
Services
1,085,349
INFORMATION
TECHNOLOGY
40.6%
Electronic
Equipment,
Instruments
&
Components
0.2%
TE
Connectivity (2)
713,093
88,088
88,088
IT
Services
1.3%
MongoDB (1)
813,881
281,489
Shopify,
Class
A (1)(2)
4,856,453
265,017
T.
ROWE
PRICE
Blue
Chip
Growth
Fund
4
Shares/Par
$
Value
(Cost
and
value
in
$000s)
‡
Snowflake,
Class
A (1)
648,003
98,995
645,501
Semiconductors
&
Semiconductor
Equipment
9.5%
Advanced
Micro
Devices (1)
2,738,085
281,530
ASML
Holding
881,534
518,924
Lam
Research (2)
149,455
93,674
Marvell
Technology
2,485,175
134,523
Monolithic
Power
Systems (2)
581,657
268,726
NVIDIA
7,328,576
3,187,857
Taiwan
Semiconductor
Manufacturing,
ADR (2)
1,860,016
161,635
Texas
Instruments
1,050,484
167,037
4,813,906
Software
19.5%
Atlassian,
Class
A (1)
932,886
187,986
BILL
Holdings (1)(2)
1,502,396
163,115
Canva,
Acquisition
Date:
8/16/21
-
12/17/21,
Cost $99,124 (1)(3)
(4)
58,155
62,032
Confluent,
Class
A (1)(2)
2,198,661
65,102
Crowdstrike
Holdings,
Class
A (1)
501,317
83,911
Datadog,
Class
A (1)(2)
980,033
89,271
Fortinet (1)
842,062
49,412
Gusto,
Acquisition
Date:
10/4/21,
Cost $32,574 (1)(3)(4)
1,131,497
17,402
Intuit
1,232,979
629,978
Microsoft
21,520,952
6,795,241
ServiceNow (1)
2,010,480
1,123,778
Synopsys (1)
1,381,430
634,035
9,901,263
Technology
Hardware,
Storage
&
Peripherals
10.1%
Apple
30,161,711
5,163,986
5,163,986
Total
Information
Technology
20,612,744
MATERIALS
0.9%
Chemicals
0.9%
Linde
660,344
245,879
Sherwin-Williams
884,637
225,627
Total
Materials
471,506
UTILITIES
0.5%
Electric
Utilities
0.5%
Constellation
Energy
2,187,312
238,592
Total
Utilities
238,592
Total
Common
Stocks
(Cost
$18,499,831)
50,345,692
T.
ROWE
PRICE
Blue
Chip
Growth
Fund
5
Shares/Par
$
Value
(Cost
and
value
in
$000s)
‡
CONVERTIBLE
PREFERRED
STOCKS
0.3%
INFORMATION
TECHNOLOGY
0.3%
Software
0.3%
Canva,
Series
A,
Acquisition
Date:
11/4/21
-
12/17/21,
Cost $6,254 (1)(3)(4)
3,669
3,914
Canva,
Series
A-3,
Acquisition
Date:
11/4/21
-
12/17/21,
Cost $699 (1)(3)(4)
410
437
Canva,
Series
A-4,
Acquisition
Date:
11/4/21
-
12/17/21,
Cost $77 (1)(3)(4)
45
48
Canva,
Series
A-5,
Acquisition
Date:
11/4/21,
Cost $14 (1)(3)(4)
8
8
Databricks,
Series
G,
Acquisition
Date:
2/1/21,
Cost $31,087 (1)
(3)(4)
525,810
38,647
Databricks,
Series
H,
Acquisition
Date:
8/31/21,
Cost $93,418 (1)
(3)(4)
1,271,268
93,438
Databricks,
Series
I,
Acquisition
Date:
9/14/23,
Cost $10,422 (1)
(3)(4)
141,790
10,422
Gusto,
Series
E,
Acquisition
Date:
7/13/21,
Cost $46,365 (1)(3)(4)
1,525,418
23,461
Total
Information
Technology
170,375
Total
Convertible
Preferred
Stocks
(Cost
$188,336)
170,375
CORPORATE
BONDS
0.2%
Carvana,
12.00%,
12/1/28,
(12.00%
PIK) (5)(6)
33,420,540
25,985
Carvana,
13.00%,
6/1/30,
(13.00%
PIK) (5)(6)
50,130,810
38,977
Carvana,
14.00%,
6/1/31,
(14.00%
PIK) (5)(6)
59,321,458
46,122
Total
Corporate
Bonds
(Cost
$123,593)
111,084
SHORT-TERM
INVESTMENTS
0.3%
Money
Market
Funds
0.3%
T.
Rowe
Price
Government
Reserve
Fund,
5.40% (7)(8)
132,057,761
132,058
Total
Short-Term
Investments
(Cost
$132,058)
132,058
T.
ROWE
PRICE
Blue
Chip
Growth
Fund
6
Shares/Par
$
Value
(Cost
and
value
in
$000s)
‡
SECURITIES
LENDING
COLLATERAL
0.2%
INVESTMENTS
IN
A
POOLED
ACCOUNT
THROUGH
SECURITIES
LENDING
PROGRAM
WITH
STATE
STREET
BANK
AND
TRUST
COMPANY
0.2%
Money
Market
Funds
0.2%
T.
Rowe
Price
Government
Reserve
Fund,
5.40% (7)(8)
83,544,718
83,545
Total
Investments
in
a
Pooled
Account
through
Securities
Lending
Program
with
State
Street
Bank
and
Trust
Company
83,545
Total
Securities
Lending
Collateral
(Cost
$83,545)
83,545
Total
Investments
in
Securities
99.9%
(Cost
$19,027,363)
$
50,842,754
Other
Assets
Less
Liabilities
0.1%
41,253
Net
Assets
100.0%
$
50,884,007
‡
Shares/Par
are
denominated
in
U.S.
dollars
unless
otherwise
noted.
(1)
Non-income
producing
(2)
All
or
a
portion
of
this
security
is
on
loan
at
September
30,
2023.
(3)
Level
3
in
fair
value
hierarchy.
(4)
Security
cannot
be
offered
for
public
resale
without
first
being
registered
under
the
Securities
Act
of
1933
and
related
rules
("restricted
security").
Acquisition
date
represents
the
day
on
which
an
enforceable
right
to
acquire
such
security
is
obtained
and
is
presented
along
with
related
cost
in
the
security
description.
The
fund
may
have
registration
rights
for
certain
restricted
securities.
Any
costs
related
to
such
registration
are
generally
borne
by
the
issuer.
The
aggregate
value
of
restricted
securities
(excluding
144A
holdings)
at
period
end
amounts
to
$286,956
and
represents
0.6%
of
net
assets.
(5)
Security
was
purchased
pursuant
to
Rule
144A
under
the
Securities
Act
of
1933
and
may
be
resold
in
transactions
exempt
from
registration
only
to
qualified
institutional
buyers.
Total
value
of
such
securities
at
period-end
amounts
to
$111,084
and
represents
0.2%
of
net
assets.
(6)
Security
has
the
ability
to
pay
in-kind
or
pay
in
cash.
When
applicable,
separate
rates
of
such
payments
are
disclosed.
(7)
Seven-day
yield
(8)
Affiliated
Companies
ADR
American
Depositary
Receipts
EUR
Euro
PIK
Payment-in-kind
T.
ROWE
PRICE
Blue
Chip
Growth
Fund
7
The
accompanying
notes
are
an
integral
part
of
this
Portfolio
of
Investments.
AFFILIATED
COMPANIES
($000s)
The
fund
may
invest
in
certain
securities
that
are
considered
affiliated
companies.
As
defined
by
the
1940
Act,
an
affiliated
company
is
one
in
which
the
fund
owns
5%
or
more
of
the
outstanding
voting
securities,
or
a
company
that
is
under
common
ownership
or
control.
The
following
securities
were
considered
affiliated
companies
for
all
or
some
portion
of
the
nine
months
ended
September
30,
2023.
Net
realized
gain
(loss),
investment
income,
change
in
net
unrealized
gain/loss,
and
purchase
and
sales
cost
reflect
all
activity
for
the
period
then
ended.
Affiliate
Net
Realized
Gain
(Loss)
Change
in
Net
Unrealized
Gain/Loss
Investment
Income
T.
Rowe
Price
Government
Reserve
Fund,
5.40%
$
—
$
—
$
2,958++
Totals
$
—#
$
—
$
2,958+
Supplementary
Investment
Schedule
Affiliate
Value
12/31/22
Purchase
Cost
Sales
Cost
Value
09/30/23
T.
Rowe
Price
Government
Reserve
Fund,
5.40%
$
207,204
¤
¤
$
215,603
Total
$
215,603^
#
Capital
gain
distributions
from
underlying
Price
funds
represented
$0
of
the
net
realized
gain
(loss).
++
Excludes
earnings
on
securities
lending
collateral,
which
are
subject
to
rebates
and
fees.
+
Investment
income
comprised
$2,958
of
dividend
income
and
$0
of
interest
income.
¤
Purchase
and
sale
information
not
shown
for
cash
management
funds.
^
The
cost
basis
of
investments
in
affiliated
companies
was
$215,603.
T.
ROWE
PRICE
Blue
Chip
Growth
Fund
Unaudited
Notes
to
Portfolio
of
Investments
8
T.
Rowe
Price
Blue
Chip
Growth
Fund,
Inc. (the
fund) is
registered
under
the
Investment
Company
Act
of
1940
(the
1940
Act)
as
an
open-end
management
investment
company
and
follows
accounting
and
reporting
guidance
of
the
Financial
Accounting
Standards
Board
Accounting
Standards
Codification
Topic
946.
The
accompanying
Portfolio
of
Investments
was
prepared
in
accordance
with
accounting
principles
generally
accepted
in
the
United
States
of
America
(GAAP).
For
additional
information
on
the
fund’s
significant
accounting
policies
and
investment
related
disclosures,
please
refer
to
the
fund’s most
recent
semiannual
or
annual
shareholder
report
and
its
prospectus.
VALUATION
Fair
Value
The
fund’s
financial
instruments
are
valued
at
the
close
of
the
New
York
Stock
Exchange
(NYSE),
normally
4
p.m.
ET,
each
day
the
NYSE
is
open
for
business,
and
are
reported
at
fair
value,
which
GAAP
defines
as
the
price
that
would
be
received
to
sell
an
asset
or
paid
to
transfer
a
liability
in
an
orderly
transaction
between
market
participants
at
the
measurement
date. The fund’s
Board
of
Directors
(the
Board)
has
designated
T.
Rowe
Price
Associates,
Inc.
as
the
fund’s
valuation
designee
(Valuation
Designee).
Subject
to
oversight
by
the
Board,
the
Valuation
Designee
performs
the
following
functions
in
performing
fair
value
determinations:
assesses
and
manages
valuation
risks;
establishes
and
applies
fair
value
methodologies;
tests
fair
value
methodologies;
and
evaluates
pricing
vendors
and
pricing
agents.
The
duties
and
responsibilities
of
the
Valuation
Designee
are
performed
by
its
Valuation
Committee. The
Valuation
Designee provides
periodic
reporting
to
the
Board
on
valuation
matters.
Various
valuation
techniques
and
inputs
are
used
to
determine
the
fair
value
of
financial
instruments.
GAAP
establishes
the
following
fair
value
hierarchy
that
categorizes
the
inputs
used
to
measure
fair
value:
Level
1
–
quoted
prices
(unadjusted)
in
active
markets
for
identical
financial
instruments
that
the
fund
can
access
at
the
reporting
date
Level
2
–
inputs
other
than
Level
1
quoted
prices
that
are
observable,
either
directly
or
indirectly
(including,
but
not
limited
to,
quoted
prices
for
similar
financial
instruments
in
active
markets,
quoted
prices
for
identical
or
similar
financial
instruments
in
inactive
markets,
interest
rates
and
yield
curves,
implied
volatilities,
and
credit
spreads)
T.
ROWE
PRICE
Blue
Chip
Growth
Fund
9
Level
3
–
unobservable
inputs
(including
the Valuation
Designee’s assumptions
in
determining
fair
value)
Observable
inputs
are
developed
using
market
data,
such
as
publicly
available
information
about
actual
events
or
transactions,
and
reflect
the
assumptions
that
market
participants
would
use
to
price
the
financial
instrument.
Unobservable
inputs
are
those
for
which
market
data
are
not
available
and
are
developed
using
the
best
information
available
about
the
assumptions
that
market
participants
would
use
to
price
the
financial
instrument.
GAAP
requires
valuation
techniques
to
maximize
the
use
of
relevant
observable
inputs
and
minimize
the
use
of
unobservable
inputs.
When
multiple
inputs
are
used
to
derive
fair
value,
the
financial
instrument
is
assigned
to
the
level
within
the
fair
value
hierarchy
based
on
the
lowest-level
input
that
is
significant
to
the
fair
value
of
the
financial
instrument.
Input
levels
are
not
necessarily
an
indication
of
the
risk
or
liquidity
associated
with
financial
instruments
at
that
level
but
rather
the
degree
of
judgment
used
in
determining
those
values.
Valuation
Techniques
Equity
securities,
including
exchange-traded
funds, listed
or
regularly
traded
on
a
securities
exchange
or
in
the
over-the-counter
(OTC)
market
are
valued
at
the
last
quoted
sale
price
or,
for
certain
markets,
the
official
closing
price
at
the
time
the
valuations
are
made.
OTC
Bulletin
Board
securities
are
valued
at
the
mean
of
the
closing
bid
and
asked
prices.
A
security
that
is
listed
or
traded
on
more
than
one
exchange
is
valued
at
the
quotation
on
the
exchange
determined
to
be
the
primary
market
for
such
security.
Listed
securities
not
traded
on
a
particular
day
are
valued
at
the
mean
of
the
closing
bid
and
asked
prices
for
domestic
securities
and
the
last
quoted
sale
or
closing
price
for
international
securities.
The
last
quoted
prices
of
non-U.S.
equity
securities
may
be
adjusted
to
reflect
the
fair
value
of
such
securities
at
the
close
of
the
NYSE,
if
the Valuation
Designee
determines
that
developments
between
the
close
of
a
foreign
market
and
the
close
of
the
NYSE
will
affect
the
value
of
some
or
all
of its portfolio
securities.
Each
business
day,
the
Valuation
Designee uses
information
from
outside
pricing
services
to
evaluate
the
quoted
prices
of
portfolio
securities
and,
if
appropriate,
decide whether
it
is
necessary
to
adjust
quoted
prices
to
reflect
fair
value
by
reviewing
a
variety
of
factors,
including
developments
in
foreign
markets,
the
performance
of
U.S.
securities
markets,
and
the
performance
of
instruments
trading
in
U.S.
markets
that
represent
foreign
securities
and
baskets
of
foreign
securities. The Valuation
Designee
uses
outside
pricing
services
to
provide
it
with
quoted
prices
and
information
to
evaluate
or
adjust
those
prices.
The Valuation
Designee
cannot
predict
how
often
it
will
use
quoted
prices
and
how
often
it
will
determine
it
necessary
to
adjust
those
prices
to
reflect
fair
value.
T.
ROWE
PRICE
Blue
Chip
Growth
Fund
10
Debt
securities
generally
are
traded
in
the over-the-counter
(OTC)
market
and
are
valued
at
prices
furnished
by
independent
pricing
services
or
by
broker
dealers
who
make
markets
in
such
securities.
When
valuing
securities,
the
independent
pricing
services
consider
factors
such
as,
but
not
limited
to,
the
yield
or
price
of
bonds
of
comparable
quality,
coupon,
maturity,
and
type,
as
well
as
prices
quoted
by
dealers
who
make
markets
in
such
securities.
Investments
denominated
in
foreign
currencies
are
translated
into
U.S.
dollar
values
each
day
at
the
prevailing
exchange
rate,
using
the
mean
of
the
bid
and
asked
prices
of
such
currencies
against
U.S.
dollars
as
provided
by
an
outside
pricing
service.
Investments
in
mutual
funds
are
valued
at
the
mutual
fund’s
closing
NAV
per
share
on
the
day
of
valuation.
Investments
for
which
market
quotations are
not
readily
available
or
deemed
unreliable
are
valued
at
fair
value
as
determined
in
good
faith
by
the
Valuation
Designee.
The
Valuation
Designee
has
adopted
methodologies
for
determining
the
fair
value
of
investments
for
which
market
quotations
are
not
readily
available
or
deemed
unreliable,
including
the
use
of
other
pricing
sources.
Factors
used
in
determining
fair
value
vary
by
type
of
investment
and
may
include
market
or
investment
specific
considerations.
The
Valuation
Designee typically
will
afford
greatest
weight
to
actual
prices
in
arm’s
length
transactions,
to
the
extent
they
represent
orderly
transactions
between
market
participants,
transaction
information
can
be
reliably
obtained,
and
prices
are
deemed
representative
of
fair
value.
However,
the
Valuation
Designee may
also
consider
other
valuation
methods
such
as
market-based
valuation
multiples;
a
discount
or
premium
from
market
value
of
a
similar,
freely
traded
security
of
the
same
issuer;
discounted
cash
flows;
yield
to
maturity;
or
some
combination.
Fair
value
determinations
are
reviewed
on
a
regular
basis.
Because
any
fair
value
determination
involves
a
significant
amount
of
judgment,
there
is
a
degree
of
subjectivity
inherent
in
such
pricing
decisions. Fair
value
prices
determined
by
the
Valuation
Designee could
differ
from
those
of
other
market
participants,
and
it
is
possible
that
the
fair
value
determined
for
a
security
may
be
materially
different
from
the
value
that
could
be
realized
upon
the
sale
of
that
security.
T.
ROWE
PRICE
Blue
Chip
Growth
Fund
11
Valuation
Inputs
The
following
table
summarizes
the
fund’s
financial
instruments,
based
on
the
inputs
used
to
determine
their
fair
values
on
September
30,
2023
(for
further
detail
by
category,
please
refer
to
the
accompanying
Portfolio
of
Investments):
OTHER
MATTERS
Unpredictable
events
such
as
environmental
or
natural
disasters,
war,
terrorism,
pandemics,
outbreaks
of
infectious
diseases,
and
similar
public
health
threats
may
significantly
affect
the
economy
and
the
markets
and
issuers
in
which
the fund
invests.
Certain
events
may
cause
instability
across
global
markets,
including
reduced
liquidity
and
disruptions
in
trading
markets,
while
some
events
may
affect
certain
geographic
regions,
countries,
sectors,
and
industries
more
significantly
than
others,
and
exacerbate
other
pre-existing
political,
social,
and
economic
risks.
Since
2020,
a
novel
strain
of
coronavirus
(COVID-19)
has
resulted
in
disruptions
to
global
business
activity
and
caused
significant
volatility
and
declines
in
global
financial
markets.
In
February
2022,
Russian
forces
entered
Ukraine
and
commenced
an
armed
conflict
leading
to
economic
sanctions
being
imposed
on
Russia
and
certain
of
its
citizens,
creating
impacts
on
Russian-related
stocks
and
debt
and
greater
volatility
in
global
markets.
In
March
2023,
the
collapse
of
some
US
regional
and
global
banks
as
well
as
overall
concerns
around
the
soundness
and
stability
of
the
global
banking
sector
has
sparked
concerns
of
a
broader
financial
crisis
impacting
the
overall
global
banking
sector.
In
certain
cases,
government
agencies
have
assumed
control
or
otherwise
intervened
in
the
operations
of
certain
banks
due
to
liquidity
and
solvency
concerns.
The
extent
of
impact
of
these
events
on
the
US
and
global
markets
is
highly
uncertain.
($000s)
Level
1
Level
2
Level
3
Total
Value
Assets
Corporate
Bonds
$
—
$
111,084
$
—
$
111,084
Common
Stocks
50,152,705
76,406
116,581
50,345,692
Convertible
Preferred
Stocks
—
—
170,375
170,375
Short-Term
Investments
132,058
—
—
132,058
Securities
Lending
Collateral
83,545
—
—
83,545
Total
$
50,368,308
$
187,490
$
286,956
$
50,842,754
T.
ROWE
PRICE
Blue
Chip
Growth
Fund
12
These
are
recent
examples
of
global
events
which
may
have
a
negative
impact
on
the
values
of
certain
portfolio
holdings
or
the
fund’s
overall
performance.
Management
is
actively
monitoring
the
risks
and
financial
impacts
arising
from
these
events.
F93-054Q3
09/23